Volume 49, Issue 2, Pages (February 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 61, Issue 5, Pages (May 2012)
Volume 68, Issue 6, Pages (December 2015)
Volume 155, Issue 3, Pages (March 1996)
The PSA Era is not Over for Prostate Cancer
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Validation of 2001 Partin Tables in Turkey: A Multicenter Study
Volume 58, Issue 2, Pages (August 2010)
Volume 44, Issue 6, Pages (December 2003)
Volume 47, Issue 4, Pages (April 2005)
Volume 58, Issue 1, Pages (July 2010)
Volume 61, Issue 5, Pages (May 2012)
Volume 46, Issue 3, Pages (September 2004)
Volume 53, Issue 5, Pages (May 2008)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 68, Issue 3, Pages (September 2015)
Volume 69, Issue 1, Pages (January 2016)
Volume 51, Issue 4, Pages (April 2007)
Volume 69, Issue 1, Pages (January 2016)
Volume 51, Issue 3, Pages (March 2007)
Volume 73, Issue 3, Pages (March 2018)
Volume 70, Issue 2, Pages (August 2016)
Volume 52, Issue 4, Pages (October 2007)
Volume 63, Issue 6, Pages (June 2013)
Volume 63, Issue 4, Pages (April 2013)
John P. Mulhall, Francesco Montorsi  European Urology 
Volume 63, Issue 1, Pages (January 2013)
Volume 59, Issue 6, Pages (June 2011)
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 53, Issue 4, Pages (April 2008)
Volume 62, Issue 1, Pages (July 2012)
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 61, Issue 4, Pages (April 2012)
The PSA Era is not Over for Prostate Cancer
Volume 53, Issue 2, Pages (February 2008)
Volume 61, Issue 5, Pages (May 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Volume 61, Issue 2, Pages (February 2012)
Volume 58, Issue 1, Pages 1-7 (July 2010)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 59, Issue 1, Pages (January 2011)
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.
Volume 47, Issue 1, Pages (January 2005)
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.
Volume 70, Issue 2, Pages (August 2016)
Volume 49, Issue 4, Pages (April 2006)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Long-Term Hormonal Therapy: Who Would Benefit?
European Urology Oncology
European Urology is “Your” Journal
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Axel Heidenreich  European Urology Supplements 
Volume 53, Issue 5, Pages (May 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 17, Issue 2, Pages (February 1950)
Volume 53, Issue 6, Pages (June 2008)
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Bertrand Tombal, Richard Berges
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Presentation transcript:

Volume 49, Issue 2, Pages 293-302 (February 2006) Pre-operative Percent Free PSA Predicts Clinical Outcomes in Patients Treated with Radical Prostatectomy with Total PSA Levels below 10ng/ml  Shahrokh F. Shariat, Khaled F. Abdel-Aziz, Claus G. Roehrborn, Yair Lotan  European Urology  Volume 49, Issue 2, Pages 293-302 (February 2006) DOI: 10.1016/j.eururo.2005.10.027 Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 1 Receiver operating curves of pre-operative percent free PSA (%F-PSA) and total PSA (T-PSA) for prediction of (A) organ confined disease, (B) seminal vesicle invasion, and (C) lympho-vascular invasion. AUC=Area under the curve; CI=Confidence interval. European Urology 2006 49, 293-302DOI: (10.1016/j.eururo.2005.10.027) Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 2 Probabilities of PSA progression-free survival in 402 consecutive patients who underwent radical prostatectomy for clinically localized disease according to quartiles of pre-operative percent free PSA. European Urology 2006 49, 293-302DOI: (10.1016/j.eururo.2005.10.027) Copyright © 2005 Elsevier B.V. Terms and Conditions